Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis.
<h4>Background</h4>Circulating immune cells including autoreactive T cells and monocytes have been documented as key players in maintaining, protecting and repairing the central nervous system (CNS) in health and disease. Here, we hypothesized that neurodegenerative diseases might be ass...
Saved in:
Main Authors: | Ilan Vaknin, Gilad Kunis, Omer Miller, Oleg Butovsky, Shay Bukshpan, David R Beers, Jenny S Henkel, Eti Yoles, Stanley H Appel, Michal Schwartz |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/229b39d1adf24f5281f19de1c1c36e4f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
by: Ghareghani Majid, et al.
Published: (2021) -
Translational utility of experimental autoimmune encephalomyelitis: recent developments
by: Guerreiro-Cacais AO, et al.
Published: (2015) -
Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats
by: Ana Milosevic, et al.
Published: (2021) -
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
by: M José Mansilla, et al.
Published: (2014) -
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Dhaiban S, et al.
Published: (2020)